Bonomi Francesca, Harder Yves, Treglia Giorgio, De Monti Marco, Parodi Corrado
Department of Surgery, Ospedale Beata Vergine di Mendrisio, Ente Ospedaliero Cantonale (EOC), Mendrisio, Switzerland.
Department of Plastic, Reconstructive and Aesthetic Surgery, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale (EOC), Lugano, Switzerland; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
J Plast Reconstr Aesthet Surg. 2024 Feb;89:144-153. doi: 10.1016/j.bjps.2023.12.009. Epub 2023 Dec 12.
BACKGROUND: Gigantomastia is a debilitating condition characterised by an excessive breast tissue growth impacting patients' quality of life. Surgically treatment options include the limited-length pedicle (LP) technique with free nipple grafting (FNG) and the elongated pedicle (EP) technique, which maintains continuity of the nipple-areola complex (NAC). Initially, despite the less satisfactory aesthetic outcome, FNG was preferred to treat hypertrophic breasts requiring resections over 1000 g of parenchymal and adipose tissue, due to concerns about NAC perfusion. Recently, many studies have questioned this indication. The aim of this study was therefore to evaluate the safety of the NAC-carrying EP technique in patients with gigantomastia eventually challenging the need for FNG. METHODS: A literature search using PubMed and Cochrane databases was performed, including studies describing the outcome of EP technique for resection exceeding 1000 g of breast tissue. Thereby, a meta-analysis was conducted to evaluate the rate of NAC necrosis, whereas a descriptive statistic was applied to assess all other surgery-associated complications. RESULTS: Twenty-five studies, encompassing 1355 patients (2656 breasts), were included. EP demonstrated an extremely low rate of NAC necrosis. Moreover, the analysis demonstrated a low rate of ischaemia-independent complications and a very high probability of maintaining NAC-sensation equal to the preoperative state. CONCLUSION: Current evidence indicates that the EP technique should be the preferred surgical method to treat gigantomastia with or without massive ptosis whenever indicated. It has proven to be safe. Furthermore, it yields superior aesthetic and functional outcomes, including breast feeding and preservation of NAC-sensation compared to the LP technique.
背景:巨乳症是一种使人衰弱的病症,其特征是乳腺组织过度生长,影响患者的生活质量。手术治疗方案包括带游离乳头移植(FNG)的有限长度蒂(LP)技术和保留乳头乳晕复合体(NAC)连续性的延长蒂(EP)技术。最初,尽管美学效果不太理想,但由于担心NAC灌注问题,对于需要切除超过1000克实质和脂肪组织的肥大乳房,FNG仍是首选的治疗方法。最近,许多研究对这一适应证提出了质疑。因此,本研究的目的是评估携带NAC的EP技术在巨乳症患者中的安全性,最终挑战FNG的必要性。 方法:使用PubMed和Cochrane数据库进行文献检索,纳入描述切除超过1000克乳腺组织的EP技术结果的研究。由此,进行荟萃分析以评估NAC坏死率,而应用描述性统计来评估所有其他与手术相关的并发症。 结果:纳入25项研究,共1355例患者(2656侧乳房)。EP显示NAC坏死率极低。此外,分析表明缺血无关并发症发生率低,维持NAC感觉与术前状态相当的可能性非常高。 结论:目前的证据表明,无论何时有指征,EP技术都应是治疗伴有或不伴有重度乳房下垂的巨乳症的首选手术方法。它已被证明是安全的。此外,与LP技术相比,它能产生更好的美学和功能效果,包括母乳喂养和保留NAC感觉。
J Plast Reconstr Aesthet Surg. 2024-2
Cochrane Database Syst Rev. 2017-8-22
J Plast Reconstr Aesthet Surg. 2017-2
Cochrane Database Syst Rev. 2016-11-29
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2021-9-23
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2021-10-29
Plast Reconstr Surg Glob Open. 2024-6-19